Minireview: Dynamic Structures of Nuclear Hormone Receptors: New Promises and Challenges
Open accessThe DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Therapeutic targeting of nuclear receptors (NRs) is presently restricted due to 2 constraints: 1) a limited knowledge of the structural dynamics of intact receptor when complexed to DNA and coregulatory proteins; and 2) the inability to more selectively modulate NR actions at specific organ/gene targets. A major obstacle has been the current lack of understanding about the function and structure of the intrinsically disordered N-terminal domain that contains a major regulatory transcriptional activation function (AF1). Current studies of both mechanism of action and small molecule-selective receptor modulators for clinical uses target the structured pocket of the ligand-binding domain to modulate coregulatory protein interactions with the other activation function AF2. However, these approaches overlook AF1 activity. Recent studies have shown that highly flexible intrinsically disordered regions of transcription factors, including that of the N-terminal domain AF1 of NRs, not only are critical for several aspects of NR action but also can be exploited as drug targets, thereby opening unique opportunities for endocrine-based therapies. In this review article, we discuss the role of structural flexibilities in the allosteric modulation of NR activity and future perspectives for therapeutic interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Two types of estrogen receptors (ERs) have been identified, the alpha (ERα) and beta (ERβ) receptors [48, 49].”
From Estrogen deficiency and the origin of obesity during menopause (2014) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kitagawa, H., Yanagisawa, J., Fuse, H., Ogawa, S., Yogiashi, Y., Okuno, A., Nagasawa, H., Nakajima, T., Matsumoto, T., & Kato, S. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3698-3706.2002 · Cited by 101
RetractedMolecular basis of agonism and antagonism in the oestrogen receptor
Brzozowski, A. M., Pike, A. C. W., Dauter, Z., Hubbard, R. E., Bonn, T., Engström, O., Öhman, L., Greene, G. L., Gustafsson, J.-Å., & Carlquist, M. (1997) · Nature · doi:10.1038/39645 · Cited by 3,355 · cited 1×
“Due to available LBD/AF2 crystal structures and the disordered nature of NTD/AF1, rational structure-based design of SRMs has been limited by necessity to how compounds modulate coregulatory protein interactions with AF2 (7), thereby neglecting AF1.”
BackgroundShiau, A. K., Barstad, D., Loria, P. M., Cheng, L., Kushner, P. J., Agard, D. A., & Greene, G. L. (1998) · Cell · doi:10.1016/s0092-8674(00)81717-1 · Cited by 2,729
Wright, P. E., & Dyson, H. J. (2009) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2008.12.003 · Cited by 1,019
Structure of the intact PPAR-γ–RXR-α nuclear receptor complex on DNA
Chandra, V., Huang, P., Hamuro, Y., Raghuram, S., Wang, Y., Burris, T. P., & Rastinejad, F. (2008) · Nature · doi:10.1038/nature07413 · Cited by 808 · cited 8×
“The quaternary structure of HNF-4 also indicates how 2 posttranslational modifications (Arg91 methylation and Ser78 phosphorylation) located in a unique position within the interdomain convergence zone can affect the DNA binding activity of the receptor (42).”
BackgroundMethodInfluentialIntrinsic Disorder in Transcription Factors
Liu, J., Perumal, N. B., Oldfield, C. J., Su, E. W., Uversky, V. N., & Dunker, A. K. (2006) · Biochemistry · doi:10.1021/bi0602718 · Cited by 792 · cited 1×
“In fact, most activation domains of transcription factors contain IDRs that have been refractory to crystallization (13, 14).”
BackgroundBerry, M., Metzger, D., & Chambon, P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07469.x · Cited by 767 · cited 1×
“for the tissue-specific effects of the SRMs (30, 58, 59).”
BackgroundMultiple and cooperative trans-activation domains of the human glucocorticoid receptor
Hollenberg, S. M., & Evans, R. M. (1988) · Cell · doi:10.1016/0092-8674(88)90145-6 · Cited by 684
DNA binding site sequence directs glucocorticoid receptor structure and activity
Meijsing, S. H., Pufall, M. A., So, A. Y., Bates, D. L., Chen, L., & Yamamoto, K. R. (2009) · Science · doi:10.1126/science.1164265 · Cited by 673
Estrogen Receptor-Associated Proteins: Possible Mediators of Hormone-Induced Transcription
Halachmi, S., Marden, E., Martin, G., MacKay, H., Abbondanza, C., & Brown, M. (1994) · Science · doi:10.1126/science.8197458 · Cited by 637
Andersen, R. J., Mawji, N. R., Wang, J., Wang, G., Haile, S., Myung, J.-K., Watt, K., Tam, T., Yang, Y. C., Bañuelos, C. A., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.04.027 · Cited by 503 · cited 2×
“Recently, a small molecule, a bisphenol A ester derivative (EPI-001) was found to interact with NTD/AF1 of AR and differentially disrupt both AF1-coactivator binding and subsequent AR AF1-regulated target gene expression (92).”
BackgroundCharacterization of Molecular Recognition Features, MoRFs, and Their Binding Partners
Vacic, V., Oldfield, C. J., Mohan, A., Radivojac, P., Cortese, M. S., Uversky, V. N., & Dunker, A. K. (2007) · Journal of Proteome Research · doi:10.1021/pr0701411 · Cited by 483
Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators
Demarest, S. J., Martinez-Yamout, M., Chung, J., Chen, H., Xu, W., Dyson, H. J., Evans, R. M., & Wright, P. E. (2002) · Nature · doi:10.1038/415549a · Cited by 452 · cited 1×
“Other unrelated proteins have also been reported to bind and induce folding of the NTD/AF1s of SHRs including transcription factor IIF, CREB-binding protein, receptor-interacting protein 140 and silencing mediator of retinoid and thyroid hormone receptor (16, 20, 24, 25, 32, 36).”
BackgroundOnate, S. A., Boonyaratanakornkit, V., Spencer, T. E., Tsai, S. Y., Tsai, M.-J., Edwards, D. P., & O'Malley, B. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12101 · Cited by 417 · cited 1×
“With NRs, both the ligand-dependent AF2 and AF1 are interaction surfaces for coregulatory proteins, including coactivators or corepressors (5, 11, 30).”
BackgroundSelf-citationPartial Agonists Activate PPARγ Using a Helix 12 Independent Mechanism
Bruning, J. B., Chalmers, M. J., Prasad, S., Busby, S. A., Kamenecka, T. M., He, Y., Nettles, K. W., & Griffin, P. R. (2007) · Structure · doi:10.1016/j.str.2007.07.014 · Cited by 389 · cited 1×
“Sequencing of peptides from digests of the intact protein enables assignment of exchange kinetics for specific regions (26, 27).”
BackgroundPeptide Antagonists of the Human Estrogen Receptor
Norris, J. D., Paige, L. A., Christensen, D. J., Chang, C.-Y., Huacani, M. R., Fan, D., Hamilton, P. T., Fowlkes, D. M., & McDonnell, D. P. (1999) · Science · doi:10.1126/science.285.5428.744 · Cited by 373 · cited 2×
“Also, several peptide probes have been identified that recognize different conformations of SRM-bound SHRs and selectively disrupt receptor-coregulatory protein complexes in a tissue-specific manner (3, 63).”
BackgroundModulation of allostery by protein intrinsic disorder
Ferreon, A. C. M., Ferreon, J. C., Wright, P. E., & Deniz, A. A. (2013) · Nature · doi:10.1038/nature12294 · Cited by 314 · cited 1×
“quences depending on the available ID-binding sites (15).”
BackgroundA surface on the androgen receptor that allosterically regulates coactivator binding
Estébanez-Perpiñá, E., Arnold, L. A., Nguyen, P., Rodrigues, E. D., Mar, E., Bateman, R., Pallai, P., Shokat, K. M., Baxter, J. D., Guy, R. K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708036104 · Cited by 307 · cited 1×
“For example, the potential for allosteric modulators of SHR function was emphasized by the finding that a small molecule, 3,3 ,5-triiodothyroacetic acid, which binds to a hydrophobic surface of the LBD distinct from the ligand-binding pocket, as well as AF2, disrupts AF2-dependent AR transactivation (66).”
BackgroundAn androgen receptor N-terminal domain antagonist for treating prostate cancer
Myung, J.-K., Banuelos, C. A., Fernandez, J. G., Mawji, N. R., Wang, J., Tien, A. H., Yang, Y. C., Tavakoli, I., Haile, S., Watt, K., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66398 · Cited by 305 · cited 1×
“with endogenous AR in living cells and inhibits the constitutively active AR splice variants lacking the LBD that are suspected to be a cause of resistance in castration-recurrent prostate cancers (93).”
BackgroundProbing Protein Ligand Interactions by Automated Hydrogen/Deuterium Exchange Mass Spectrometry
Chalmers, M. J., Busby, S. A., Pascal, B. D., He, Y., Hendrickson, C. L., Marshall, A. G., & Griffin, P. R. (2006) · Analytical Chemistry · doi:10.1021/ac051294f · Cited by 301 · cited 1×
“Sequencing of peptides from digests of the intact protein enables assignment of exchange kinetics for specific regions (26, 27).”
BackgroundNuclear receptor coregulators: modulators of pathology and therapeutic targets
Lonard, D. M., & O'Malley, B. W. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.100 · Cited by 272 · cited 2×
“With NRs, both the ligand-dependent AF2 and AF1 are interaction surfaces for coregulatory proteins, including coactivators or corepressors (5, 11, 30).”
BackgroundMultiple Signal Input and Output Domains of the 160-Kilodalton Nuclear Receptor Coactivator Proteins
Ma, H., Hong, H., Huang, S.-M., Irvine, R. A., Webb, P., Kushner, P. J., Coetzee, G. A., & Stallcup, M. R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6164 · Cited by 256 · cited 2×
“Interaction of SRC-1 and activation domain 2 can stimulate NTD/AF1 of AR (37) whereas TIF2.”
BackgroundDevelopment of subtype-selective oestrogen receptor-based therapeutics
Nilsson, S., Koehler, K. F., & Gustafsson, J.-Å. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3551 · Cited by 249 · cited 4×
“This includes the NTD/AF1 of glucocorticoid (GR), mineralocorticoid (MR), estrogen (ER), androgen (AR), and progesterone receptors (PRs) that undergo an 174 Simons et al Dynamic Structures of Nuclear Hormone Receptors Mol Endocrinol, February 2014, 28(2):173–182”
BackgroundInfluentialStructural Basis for an Unexpected Mode of SERM-Mediated ER Antagonism
Wu, Y.-L., Yang, X., Ren, Z., McDonnell, D. P., Norris, J. D., Willson, T. M., & Greene, G. L. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.04.014 · Cited by 232
Structure of the full human RXR/VDR nuclear receptor heterodimer complex with its DR3 target DNA
Orlov, I., Rochel, N., Moras, D., & Klaholz, B. P. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.445 · Cited by 218 · cited 1×
“Interestingly, the short NTD of vitamin D receptor (VDR) in the cryo-EM structure of DNA-bound RXR/VDR was visible and localized near the major groove of DNA adjacent to the VDR-bound DR3 element, suggesting the NTD may have a direct role in modulating DNA binding (53).”
BackgroundMultidomain integration in the structure of the HNF-4α nuclear receptor complex
Chandra, V., Huang, P., Potluri, N., Wu, D., Kim, Y., & Rastinejad, F. (2013) · Nature · doi:10.1038/nature11966 · Cited by 206 · cited 3×
“NRs in solution exhibited a more open conformation without the domain-domain interfaces between LBDs and DBDs observed in the crystal structures of PPAR /RXR and HNF-4 homodimers (28, 42).”
BackgroundMcDonnell, D. P., & Wardell, S. E. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.09.007 · Cited by 203 · cited 2×
“Also, several peptide probes have been identified that recognize different conformations of SRM-bound SHRs and selectively disrupt receptor-coregulatory protein complexes in a tissue-specific manner (3, 63).”
BackgroundDNA binding alters coactivator interaction surfaces of the intact VDR–RXR complex
Zhang, J., Chalmers, M. J., Stayrook, K. R., Burris, L. L., Wang, Y., Busby, S. A., Pascal, B. D., Garcia-Ordonez, R. D., Bruning, J. B., Istrate, M. A., et al. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2046 · Cited by 201
Rochel, N., Ciesielski, F., Godet, J., Moman, E., Roessle, M., Peluso-Iltis, C., Moulin, M., Haertlein, M., Callow, P., Mély, Y., et al. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2054 · Cited by 193
Drugs for ‘protein clouds’: targeting intrinsically disordered transcription factors
Dunker, A. K., & Uversky, V. N. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.09.005 · Cited by 174 · cited 3×
“Drugs have been defined that interfere with intrinsic disorder-to-order transition induced by a binding protein by either directly interacting with IDRs of the transcription factor (ie, c-myc and EWSFLI1) and causing misfolding or by targeting a structural motif in the protein binding partner (ie, p53) (14).”
BackgroundJohnson, A. B., & O’Malley, B. W. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.04.021 · Cited by 164 · cited 1×
“With NRs, both the ligand-dependent AF2 and AF1 are interaction surfaces for coregulatory proteins, including coactivators or corepressors (5, 11, 30).”
BackgroundFulvestrant (Faslodex®)—How to Make a Good Drug Better
Robertson, J. F. R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-7-774 · Cited by 164
The glucocorticoid receptor dimer interface allosterically transmits sequence-specific DNA signals
Watson, L. C., Kuchenbecker, K. M., Schiller, B. J., Gross, J. D., Pufall, M. A., & Yamamoto, K. R. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2595 · Cited by 163
Signal transduction via unstructured protein conduits
Dunker, A. K., & Uversky, V. N. (2008) · Nature Chemical Biology · doi:10.1038/nchembio0408-229 · Cited by 158
Wardell, S. E., Marks, J. R., & McDonnell, D. P. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.03.031 · Cited by 145 · cited 1×
“More recent studies question whether enhanced degradation of ER alone contributes to antagonist activity of fulvestrant, suggesting that altered conformation of LBD/AF2 is also involved (80).”
BackgroundBillon-Galés, A., Fontaine, C., Filipe, C., Douin‐Echinard, V., Fouque, M.-J., Flouriot, G., Gourdy, P., Lenfant, F., Laurell, H., Krust, A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808742106 · Cited by 145
Conformational Analysis of the Androgen Receptor Amino-terminal Domain Involved in Transactivation
Reid, J., Kelly, S. M., Watt, K., Price, N. C., & McEwan, I. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201003200 · Cited by 143 · cited 1×
“Other unrelated proteins have also been reported to bind and induce folding of the NTD/AF1s of SHRs including transcription factor IIF, CREB-binding protein, receptor-interacting protein 140 and silencing mediator of retinoid and thyroid hormone receptor (16, 20, 24, 25, 32, 36).”
BackgroundWardell, S. E., Nelson, E. R., Chao, C. A., & McDonnell, D. P. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3771 · Cited by 138 · cited 2×
“Another promising selective ER degrader, bazedoxifene, has an improved oral activity profile and ability to inhibit experimental tamoxifen-resistant experimental breast cancer models (82).”
BackgroundStructural plasticity in the oestrogen receptor ligand‐binding domain
Nettles, K. W., Bruning, J. B., Gil, G., O'Neill, E. E., Nowak, J., Hughs, A., Kim, Y., DeSombre, E. R., Dilis, R., Hanson, R. N., et al. (2007) · EMBO reports · doi:10.1038/sj.embor.7400963 · Cited by 137 · cited 1×
“Clinically this phenomenon has extensively been exploited with SRMs that bind to the LBD (9).”
BackgroundWärnmark, A., Wikström, A., Wright, A. P. H., Gustafsson, J.-Å., & Härd, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107875200 · Cited by 136 · cited 2×
“Thus TBP appears to act as an SHR coregulatory protein via reorganizing or stabilizing structures in the NTD for recognition by alternative surfaces of SRC-1 and assembly of coactivator complexes (20, 23, 25, 34, 35).”
BackgroundAllosteric Modulators of Steroid Hormone Receptors: Structural Dynamics and Gene Regulation
Kumar, R., & McEwan, I. J. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1033 · Cited by 135
Self-citationKumar, R., Lee, J. C., Bolen, D. W., & Thompson, E. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100825200 · Cited by 133
Self-citationReese, J. C., & Katzenellenbogen, B. S. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.23.6595 · Cited by 125
Billon-Galés, A., Krust, A., Fontaine, C., Abot, A., Flouriot, G., Toutain, C., Berges, H., Gadeau, A.-P., Lenfant, F., Gourdy, P., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105632108 · Cited by 125
Chen, W., Rogatsky, I., & Garabedian, M. J. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0318 · Cited by 123 · cited 1×
“It is well known that within the intact NRs, there is a functional synergy between AF1 and AF2 that is an essential component of SHR-mediated target gene regulation (31, 32).”
BackgroundSzapary, D. (1999) · Molecular Endocrinology · doi:10.1210/me.13.12.2108 · Cited by 122 · cited 3×
“Importantly, this last study shows that the contribution of the AF1 domain of GR in the activity of the trimeric GR/TIF2/STAMP complex varies with the composition of the other 2 factors.”
BackgroundSelf-citationInduced α-Helix Structure in AF1 of the Androgen Receptor upon Binding Transcription Factor TFIIF
Kumar, R., Betney, R., Li, J., Thompson, E. B., & McEwan, I. J. (2004) · Biochemistry · doi:10.1021/bi035934p · Cited by 107 · cited 1×
“Other unrelated proteins have also been reported to bind and induce folding of the NTD/AF1s of SHRs including transcription factor IIF, CREB-binding protein, receptor-interacting protein 140 and silencing mediator of retinoid and thyroid hormone receptor (16, 20, 24, 25, 32, 36).”
BackgroundSelf-citationNon-competitive androgen receptor inhibition in vitro and in vivo
Jones, J. O., Bolton, E. C., Huang, Y., Feau, C., Guy, R. K., Yamamoto, K. R., Hann, B., & Diamond, M. I. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807282106 · Cited by 104 · cited 1×
“For example, harmol hydrochloride and pyrvinium pamoate have been found to inhibit AR activity through interaction with the DBD, apparently by disrupting DNA binding, and by acting at a subsequent step in receptor signaling, possibly disrupting protein-protein interactions (84).”
BackgroundAgonism/antagonism switching in allosteric ensembles
Motlagh, H. N., & Hilser, V. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120519109 · Cited by 102 · cited 2×
“In addition to allosteric communication between LBD and DBD, the NTD may allosterically transmit local unfolding within the structured DBD and LBD through intramolecular interdomain interactions (33, 43).”
BackgroundInterdomain Signaling in a Two-domain Fragment of the Human Glucocorticoid Receptor
Kumar, R., Baskakov, I. V., Srinivasan, G., Bolen, D. W., Lee, J. C., & Thompson, E. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.24737 · Cited by 102
Self-citationRoles of transactivating functions 1 and 2 of estrogen receptor-α in bone
Börjesson, A. E., Windahl, S. H., Lagerquist, M. K., Engdahl, C., Frenkel, B., Movérare-Skrtic, S., Sjögren, K., Kindblom, J. M., Stubelius, A., Islander, U., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100454108 · Cited by 99
Fulvestrant - A Novel Endocrine Therapy for Breast Cancer
Johnston, S. J., & Cheung, K. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790820633 · Cited by 99
Arao, Y., Hamilton, K. J., Ray, M. K., Scott, G., Mishina, Y. M., & Korach, K. S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109180108 · Cited by 97
Wang, Q., Blackford, J. A., Song, L.-N., Huang, Y., Cho, S., & Simons, S. S. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0421 · Cited by 97
Self-citationDai, S. Y., Chalmers, M. J., Bruning, J. B., Bramlett, K. S., Osborne, H. E., Montrose‐Rafizadeh, C., Barr, R. J., Wang, Y., Wang, M., Burris, T. P., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710802105 · Cited by 97 · cited 1×
“Interestingly bazedoxifene induces conformational changes in ER distinct from tamoxifen and more comparable to fulvestrant (54, 82).”
BackgroundStructural and functional analysis of domains of the progesterone receptor
Hill, K. K., Roemer, S. C., Churchill, M. E. A., & Edwards, D. P. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.017 · Cited by 96
Self-citationGarza, A. M. S., Khan, S. H., & Kumar, R. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00552-09 · Cited by 96 · cited 1×
“GR-mediated target gene regulation (41).”
TATA box binding protein induces structure in the recombinant glucocorticoid receptor AF1 domain
Kumar, R., Volk, D. E., Li, J., Lee, J. C., Gorenstein, D. G., & Thompson, E. B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407160101 · Cited by 86
Fontaine, C., Billon-Galés, A., Filipe, C., Douin‐Echinard, V., Fouque, M.-J., Flouriot, G., Gourdy, P., Lenfant, F., Laurell, H., Krust, A., et al. (2009) · HAL · Cited by 80
Allosteric Controls of Nuclear Receptor Function in the Regulation of Transcription
Billas, I. M. L., & Moras, D. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.03.017 · Cited by 73 · cited 1×
“Similarly, coregulatory protein-induced allosteric effects that alter receptor structure and transcriptional activity are frequently analyzed in the absence of AF1 sequences either with LBD/AF2s linked to heterologous DNA binding domains or with NRs lacking the NTD (65).”
BackgroundFischer, K., Kelly, S. M., Watt, K., Price, N. C., & McEwan, I. J. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0005 · Cited by 71 · cited 5×
“Thus TBP appears to act as an SHR coregulatory protein via reorganizing or stabilizing structures in the NTD for recognition by alternative surfaces of SRC-1 and assembly of coactivator complexes (20, 23, 25, 34, 35).”
BackgroundInfluentialCheng, J., Zhang, C., & Shapiro, D. J. (2007) · Endocrinology · doi:10.1210/en.2007-0148 · Cited by 71
Devarakonda, S., Gupta, K., Chalmers, M. J., Hunt, J. F., Griffin, P. R., Van Duyne, G. D., & Spiegelman, B. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113813108 · Cited by 69
Mao, C., Patterson, N. M., Cherian, M. T., Aninye, I. O., Zhang, C., Montoya, J. B., Cheng, J., Putt, K. S., Hergenrother, P. J., Wilson, E. M., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709936200 · Cited by 66 · cited 1×
“Importantly theophylline, 8-[(benzylthio) methyl]-(7CI,8CI) is highly selective for ER vs other SHRs and inhibits growth of breast cancer cells that are resistant to tamoxifen (85).”
BackgroundThe N-terminal Region of Human Progesterone B-receptors
Bain, D. L., Franden, M. A., McManaman, J. L., Takimoto, G. S., & Horwitz, K. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102611200 · Cited by 66
Brodie, J., & McEwan, I. J. (2005) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01723 · Cited by 65
Arnal, J., Fontaine, C., Abot, A., Valera, M., Laurell, H., Gourdy, P., & Lenfant, F. (2012) · Steroids · doi:10.1016/j.steroids.2012.11.011 · Cited by 58 · cited 1×
“It is surprising that the ID NTD/AF1 has appeared to be a rather unattractive target for small-molecule inhibitors of receptor function despite 1) the development of several small-molecule inhibitors of receptor that allosterically modulate SHR functions, 2) the critical role that structural flexibility can play in al…”
BackgroundKumar, R., Moure, C. M., Khan, S. H., Callaway, C., Grimm, S. L., Goswami, D., Griffin, P. R., & Edwards, D. P. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.491787 · Cited by 58 · cited 3×
“Additionally, in studies with GR, MR, and PR, TBP-induced folding of the NTD was observed to be associated with enhancement of NTD/AF1-mediated transcriptional activity (20, 29, 34).”
BackgroundSelf-citationKhan, S. H., Awasthi, S., Guo, C., Goswami, D., Ling, J., Griffin, P. R., Simons, S. S., & Kumar, P. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.411330 · Cited by 57 · cited 2×
“Thus TBP appears to act as an SHR coregulatory protein via reorganizing or stabilizing structures in the NTD for recognition by alternative surfaces of SRC-1 and assembly of coactivator complexes (20, 23, 25, 34, 35).”
BackgroundSelf-citationA theoretical framework for gene induction and experimental comparisons
Ong, K. M., Blackford, J. A., Kagan, B. L., Simons, S. S., & Chow, C. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911095107 · Cited by 56
Self-citationNorris, J. D., Joseph, J. D., Sherk, A. B., Juzumiene, D., Turnbull, P. S., Rafferty, S. W., Cui, H., Anderson, E., Fan, D., Dye, D. A., et al. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.01.016 · Cited by 52 · cited 1×
“Furthermore, it has been possible with peptide probes to classify pharmacologic activities of SRMs by differential presentation of protein interaction surfaces of receptors (3, 63, 67, 68).”
BackgroundWardell, S. E., Kwok, S. C., Sherman, L., Hodges, R. S., & Edwards, D. P. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.20.8792-8808.2005 · Cited by 48
Self-citationInhibition of prostate cancer cell growth by second-site androgen receptor antagonists
Joseph, J. D., Wittmann, B. M., Dwyer, M. A., Cui, H. N., Dye, D. A., McDonnell, D. P., & Norris, J. D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900185106 · Cited by 42 · cited 1×
“Furthermore, it has been possible with peptide probes to classify pharmacologic activities of SRMs by differential presentation of protein interaction surfaces of receptors (3, 63, 67, 68).”
BackgroundArao, Y., Hamilton, K. J., Goulding, E. H., Janardhan, K. S., Eddy, E. M., & Korach, K. S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216189110 · Cited by 40
Khan, S. H., Ling, J., & Kumar, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021939 · Cited by 36 · cited 3×
“Additionally, in studies with GR, MR, and PR, TBP-induced folding of the NTD was observed to be associated with enhancement of NTD/AF1-mediated transcriptional activity (20, 29, 34).”
BackgroundWang, D., & Simons, S. S. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0012 · Cited by 36 · cited 3×
“NRs in solution exhibited a more open conformation without the domain-domain interfaces between LBDs and DBDs observed in the crystal structures of PPAR /RXR and HNF-4 homodimers (28, 42).”
BackgroundSelf-citationSmall Molecule Inhibitors as Probes for Estrogen and Androgen Receptor Action
Shapiro, D. J., Mao, C., & Cherian, M. T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.203026 · Cited by 35 · cited 2×
“Recent efforts to identify small molecules that act outside of the ligand-binding pocket and block NR activity are mainly focused on their interference with coactivator binding (4).”
BackgroundGlucocorticoid receptor cofactors as therapeutic targets
Simons, S. S. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.08.001 · Cited by 34 · cited 1×
“for the tissue-specific effects of the SRMs (30, 58, 59).”
BackgroundSelf-citationHill, K. K., Roemer, S. C., Jones, D. N. M., Churchill, M. E. A., & Edwards, D. P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.003244 · Cited by 32
Self-citationCho, S., Blackford, J. A., & Simons, S. S. (2005) · Biochemistry · doi:10.1021/bi048777i · Cited by 31 · cited 4×
“NRs in solution exhibited a more open conformation without the domain-domain interfaces between LBDs and DBDs observed in the crystal structures of PPAR /RXR and HNF-4 homodimers (28, 42).”
BackgroundSelf-citationGarza, A. S., Khan, S. H., Moure, C. M., Edwards, D. P., & Kumar, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025875 · Cited by 30
Self-citationSolution Structures of PPARγ2/RXRαComplexes
Ősz, J., Pethoukhov, M. V., Sirigu, S., Svergun, D. I., Moras, D., & Rochel, N. (2012) · PPAR Research · doi:10.1155/2012/701412 · Cited by 27
Sistare, F. D., Hager, G. L., & Simons, S. S. (1987) · Molecular Endocrinology · doi:10.1210/mend-1-9-648 · Cited by 26 · cited 1×
“Reduced ligand affinity for SR may account for some effects but cannot explain the antagonist activity of covalent receptor-steroid complexes like those of GR with dexamethasone mesylate (64).”
BackgroundSelf-citationKretzer, N. M., Cherian, M. T., Mao, C., Aninye, I. O., Reynolds, P. D., Schiff, R., Hergenrother, P. J., Nordeen, S. K., Wilson, E. M., & Shapiro, D. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.183723 · Cited by 26 · cited 2×
“Unlike fulvestrant, this compound does not compete with estrogens and acts outside of the ligand-binding pocket (83).”
BackgroundThe Role of the General Transcription Factor IIF in Androgen Receptor-Dependent Transcription
Choudhry, M. A., Ball, A., & McEwan, I. J. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0486 · Cited by 22 · cited 2×
“It is well known that within the intact NRs, there is a functional synergy between AF1 and AF2 that is an essential component of SHR-mediated target gene regulation (31, 32).”
BackgroundZhang, Z., Sun, Y., Cho, Y., Chow, C. C., & Simons, S. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.427740 · Cited by 21
Self-citationLuo, M., & Simons, S. S. (2009) · Human Immunology · doi:10.1016/j.humimm.2009.07.029 · Cited by 20 · cited 1×
“This independent regulation of EC50 and total activity (and also SRM or partial agonist activity) has been seen both with endogenous receptor gene targets upon reduction of cellular TIF2 levels with TIF2 small interfering RNA (71) and after removing selected domains of GR and coregulatory proteins (72).”
BackgroundSelf-citationThe road less traveled: New views of steroid receptor action from the path of dose–response curves
Simons, S. S., & Chow, C. C. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.05.030 · Cited by 20
Self-citationDisorder guides protein function
Whitford, P. C. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305236110 · Cited by 17 · cited 1×
“In addition to allosteric communication between LBD and DBD, the NTD may allosterically transmit local unfolding within the structured DBD and LBD through intramolecular interdomain interactions (33, 43).”
BackgroundDougherty, E. J., Guo, C., Simons, S. S., & Chow, C. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030225 · Cited by 16
Self-citationCross-talk between the ligand- and DNA-binding domains of estrogen receptor
Huang, W., Greene, G. L., Ravikumar, K. M., & Yang, S. (2013) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24331 · Cited by 16
Lee, G., & Simons, S. S. (2010) · Biochemistry · doi:10.1021/bi101792d · Cited by 16
Self-citationBlackford, J. A., Guo, C., Zhu, R., Dougherty, E. J., Chow, C. C., & Simons, S. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.414805 · Cited by 15
Self-citationAwasthi, S., & Simons, S. S. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.02.001 · Cited by 13 · cited 2×
“Interestingly, some coregulators alter the EC50 without affecting the total amount of induced product (72).”
BackgroundSelf-citation
Cited by
Estrogen deficiency and the origin of obesity during menopause
Lizcano, F., & Guzmán, G. (2014) · BioMed Research International · doi:10.1155/2014/757461 · Cited by 586
Menopause-Associated Lipid Metabolic Disorders and Foods Beneficial for Postmenopausal Women
Ko, S.-H., & Kim, H.-S. (2020) · Nutrients · doi:10.3390/nu12010202 · Cited by 516
“There are two types of estrogen receptors: estrogen alpha (ER α) and estrogen beta (ER β) receptors [75].”
BackgroundAllosteric Modulation as a Unifying Mechanism for Receptor Function and Regulation
Changeux, J.-P., & Christopoulos, A. (2016) · Cell · doi:10.1016/j.cell.2016.08.015 · Cited by 336
Nuclear receptors outside the nucleus: extranuclear signalling by steroid receptors
Levin, E. R., & Hammes, S. R. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.122 · Cited by 277
Progesterone Receptor Signaling Mechanisms
Grimm, S. L., Hartig, S. M., & Edwards, D. P. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.06.020 · Cited by 229
Self-citation
Metadata
- Authors
- Simons, S. S., Edwards, D. P., & Kumar, R.
- Affiliations
- National Institutes of Health (US)
- Baylor College of Medicine (US)
- Geisinger College of Health Sciences (US)
- Corresponding author
- Kumar, Raj
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2014-02-01
- Volume
- 28
- Issue
- 2
- Pages
- 173-182
- ISSN
- 0888-8809 (ISSN-L)
- 1944-9917
- PMC
- PMC3896641
- OpenAlex
- W1967495043
- Cited by
- 88
- References
- 94
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 4 · 2023: 5 · 2022: 3 · 2021: 9 · 2020: 7 · 2019: 12 · 2018: 6 · 2017: 8 · 2016: 12 · 2015: 7 · 2014: 5
- FWCI
- 0.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular Endocrinology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA046938, R01CA046938)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK049030, R01DK049030)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- nuclear receptors, intrinsically disordered regions, N-terminal domain, activation functions, AF-2, ligand-binding domain, allosteric modulation, structural flexibility
- MeSH terms
- Allosteric Regulation, Animals, Humans, Neoplasms, Protein Conformation, Transcriptional Activation, Receptors, Cytoplasmic and Nuclear, Molecular Targeted Therapy, Intrinsically Disordered Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.